SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193805-18-000790
Filing Date
2018-06-04
Accepted
2018-06-04 17:12:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G e618072_sc13g-cidara.htm SC 13G 225361
2 JOINT FILING AGREEMENT e618072_ex99-1.htm EX-99.1 11135
  Complete submission text file 0001193805-18-000790.txt   238193
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88806 | Film No.: 18879032
SIC: 2836 Biological Products, (No Diagnostic Substances)